A new genetic test appears to be effective for identifying women diagnosed with the earliest form of breast cancer who are least likely to suffer a recurrence, researchers reported Tuesday. The findings indicate the test could help women wrestling with one of the most difficult questions they face after being diagnosed: whether to undergo radiation and other treatment after a lumpectomy or whether they can skip the follow-up treatment. Read full article >>